Joseph Miller

Joseph Miller

No más puestos en curso

Fortuna: 10 M $ al 30/06/2026

52 años
Health Technology
Commercial Services
Consumer Services

Perfil

Joseph M.
Miller
worked as Chief Financial Officer & Vice President-Finance at Eppendorf, Inc. and Eppendorf-5 Prime, Inc. from 2002 to 2006.
From 2006 to 2015, Mr. Miller was Senior Director-Accounting at Qiagen Genomics, Inc. and QIAGEN NV.
Between 2015 and 2018, Mr. Miller served as Vice President-Finance at Sucampo Pharmaceuticals LLC.
From 2020 to 2022, Mr. Miller was Director at Avalo Therapeutics, Inc. Mr. Miller's education includes an undergraduate degree from Villanova University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
02/03/2026 576.421 ( 0,45 % ) 10 M $ 30/06/2026

Antiguos cargos conocidos de Joseph Miller.

EmpresasCargoFin
AURINIA PHARMACEUTICALS INC. Director Financiero/CFO 20/03/2026
AVALO THERAPEUTICS, INC. Director Financiero/CFO 24/04/2020
SUCAMPO PHARMACEUTICALS, INC. Director Financiero/CFO 01/04/2018
Comptroller/Controller/Auditor 01/01/2015
QIAGEN N.V. Comptroller/Controller/Auditor 01/01/2015
Ver el detalle de la experiencia de Joseph Miller.

Formación de Joseph Miller.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

55

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas8

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Eppendorf-5 Prime, Inc.

Health Technology

Health Technology